Dr Julia A Rogowski, PT, DPT | |
100 Division St Ste 70, Ansonia, CT 06401-2147 | |
(475) 216-4001 | |
(475) 216-4002 |
Full Name | Dr Julia A Rogowski |
---|---|
Gender | Female |
Speciality | Physical Therapy |
Experience | 10 Years |
Location | 100 Division St Ste 70, Ansonia, Connecticut |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144624396 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 10309 (Connecticut) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ptsma Inc | 7911800180 | 92 |
News Archive
Trauma-focused cognitive-behavioral therapy (TF-CBT) and eye movement desensitization and reprocessing (EMDR) are effective treatments for posttraumatic stress disorder.
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic diseases, today announced that Dr. Rebecca Taub, Senior Vice President Research & Development will present "Liver Directed Beta Agonist for Targeting Cardiometabolic Disease", and will discuss the Company's cardio-metabolic product portfolio, including VIA's inhibitor of 5 Lipoxygenase, its THR Beta Agonist, and its DGAT1 development programs, at the Cambridge Healthtech Institute Seventh International Discovery on Target 2009 program, on November 3, 2009 in Boston, MA.
A new temporary "electronic tattoo" developed by Tel Aviv University that can measure the activity of muscle and nerve cells researchers is poised to revolutionize medicine, rehabilitation, and even business and marketing research.
Dr. Reddy's Laboratories today announced that it has launched three products in the US market.
› Verified 9 days ago
Provider Name | Ptsma Inc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1033773759 PECOS PAC ID: 7911800180 Enrollment ID: O20190712000494 |
News Archive
Trauma-focused cognitive-behavioral therapy (TF-CBT) and eye movement desensitization and reprocessing (EMDR) are effective treatments for posttraumatic stress disorder.
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic diseases, today announced that Dr. Rebecca Taub, Senior Vice President Research & Development will present "Liver Directed Beta Agonist for Targeting Cardiometabolic Disease", and will discuss the Company's cardio-metabolic product portfolio, including VIA's inhibitor of 5 Lipoxygenase, its THR Beta Agonist, and its DGAT1 development programs, at the Cambridge Healthtech Institute Seventh International Discovery on Target 2009 program, on November 3, 2009 in Boston, MA.
A new temporary "electronic tattoo" developed by Tel Aviv University that can measure the activity of muscle and nerve cells researchers is poised to revolutionize medicine, rehabilitation, and even business and marketing research.
Dr. Reddy's Laboratories today announced that it has launched three products in the US market.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Julia A Rogowski, PT, DPT 13 Brookwood Ln, Shelton, CT 06484-2041 Ph: (814) 505-8901 | Dr Julia A Rogowski, PT, DPT 100 Division St Ste 70, Ansonia, CT 06401-2147 Ph: (475) 216-4001 |
News Archive
Trauma-focused cognitive-behavioral therapy (TF-CBT) and eye movement desensitization and reprocessing (EMDR) are effective treatments for posttraumatic stress disorder.
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic diseases, today announced that Dr. Rebecca Taub, Senior Vice President Research & Development will present "Liver Directed Beta Agonist for Targeting Cardiometabolic Disease", and will discuss the Company's cardio-metabolic product portfolio, including VIA's inhibitor of 5 Lipoxygenase, its THR Beta Agonist, and its DGAT1 development programs, at the Cambridge Healthtech Institute Seventh International Discovery on Target 2009 program, on November 3, 2009 in Boston, MA.
A new temporary "electronic tattoo" developed by Tel Aviv University that can measure the activity of muscle and nerve cells researchers is poised to revolutionize medicine, rehabilitation, and even business and marketing research.
Dr. Reddy's Laboratories today announced that it has launched three products in the US market.
› Verified 9 days ago
Kelly Bennett, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 25 Berkshire Rd, Ansonia, CT 06401 Phone: 203-906-2276 | |
Nolan Rufa, Physical Therapist Medicare: Medicare Enrolled Practice Location: 100 Division St Ste 70, Ansonia, CT 06401 Phone: 475-216-4001 |